Literature DB >> 20924207

EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma.

Steven S Chang1, Ian Smith, Chad Glazer, Patrick Hennessey, Joseph A Califano.   

Abstract

AIM: To discover putative oncogenes in head and neck squamous cell carcinoma (HNSCC) by integrating data from whole-genome comparison of array-based comparative genomic hybridization (CGH) and expression microarray analysis of HNSCC.
METHODS: We integrated published data defining regions of loss/gain identified from the profiling of 21 HNSCC using high-resolution (<1 Mb) CGH arrays and data from an mRNA expression microarray (approx. 12,000 genes) comparing 6 normal tissues and 8 HNSCC tumor tissues. Eukaryotic translation initiation factor 2C subunit 2 (EIF2C2) was found to be the most significantly overexpressed gene by mRNA expression array, and corresponded to the most common region of amplification found by the CGH array described by Sparano et al. We validated EIF2C2 overexpression in primary tissue, overexpression and amplification in HNSCC lines (JHU-011, JHU-012, FADU) relative to a minimally transformed oral keratinocyte cell line (OKF6) and performed knockdown experiments.
RESULTS: The tumor tissues had an average mRNA expression level of 123 (SD = 49) compared to the normal tissues (18.6, SD = 10) (p = 0.0005) by expression array. Quantitative RT-PCR validation of our expression arrays found that normal tissues had an average expression of 0.76 (SE = 0.08) and tumor tissues of 2.1 (SE = 0.35) (p = 0.0008). EIF2C2 was found to be amplified and overexpressed in 3 HNSCC cell lines. Knockdown of EIF2C2 in cell lines (JHU-012 and JHU-011) inhibited proliferation.
CONCLUSION: EIF2C2 is amplified and overexpressed in HNSCC cell lines and primary tumors and functionally significant in cell lines.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924207      PMCID: PMC2975733          DOI: 10.1159/000320597

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  13 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 2.  miRNAs, cancer, and stem cell division.

Authors:  Carlo M Croce; George A Calin
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

Review 3.  Host-virus genome interactions: macro roles for microRNAs.

Authors:  Vinod Scaria; Manoj Hariharan; Beena Pillai; Souvik Maiti; Samir K Brahmachari
Journal:  Cell Microbiol       Date:  2007-10-18       Impact factor: 3.715

4.  A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples.

Authors:  P Chomczynski
Journal:  Biotechniques       Date:  1993-09       Impact factor: 1.993

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 6.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

7.  Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.

Authors:  André Lopes Carvalho; Inês Nobuko Nishimoto; Joseph A Califano; Luiz Paulo Kowalski
Journal:  Int J Cancer       Date:  2005-05-01       Impact factor: 7.396

8.  Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization.

Authors:  Anthony Sparano; Kelly M Quesnelle; Madhu S Kumar; Yan Wang; Albert J Sylvester; Michael Feldman; Duane A Sewell; Gregory S Weinstein; Marcia S Brose
Journal:  Laryngoscope       Date:  2006-05       Impact factor: 3.325

9.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

10.  A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway.

Authors:  Dónal O'Carroll; Ingrid Mecklenbrauker; Partha Pratim Das; Angela Santana; Ulrich Koenig; Anton J Enright; Eric A Miska; Alexander Tarakhovsky
Journal:  Genes Dev       Date:  2007-07-12       Impact factor: 11.361

View more
  10 in total

1.  MicroRNA biogenesis and cellular proliferation.

Authors:  Divya Lenkala; Eric R Gamazon; Bonnie LaCroix; Hae Kyung Im; R Stephanie Huang
Journal:  Transl Res       Date:  2015-02-07       Impact factor: 7.012

2.  Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.

Authors:  Zhen-long Ye; Yao Huang; Lin-fang Li; Hai-li Zhu; Hai-xia Gao; Hui Liu; Sai-qun Lv; Zeng-hui Xu; Luo-ning Zheng; Tao Liu; Jing-lei Zhang; Hua-jun Jin; Qi-jun Qian
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

3.  Up-regulation of Ago2 expression in gastric carcinoma.

Authors:  Jin Zhang; Xiang-shan Fan; Cai-xia Wang; Biao Liu; Qin Li; Xiao-jun Zhou
Journal:  Med Oncol       Date:  2013-06-18       Impact factor: 3.064

4.  High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner.

Authors:  Sudhir Varma; Yves Pommier; Margot Sunshine; John N Weinstein; William C Reinhold
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

Review 5.  From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies.

Authors:  Vasiliki I Pantazopoulou; Stella Georgiou; Panos Kakoulidis; Stavroula N Giannakopoulou; Sofia Tseleni; Dimitrios J Stravopodis; Ema Anastasiadou
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

Review 6.  AGO unchained: Canonical and non-canonical roles of Argonaute proteins in mammals.

Authors:  Laura Sala; Srividya Chandrasekhar; Joana A Vidigal
Journal:  Front Biosci (Landmark Ed)       Date:  2020-01-01

Review 7.  Argonaute 2: A Novel Rising Star in Cancer Research.

Authors:  ZhenLong Ye; HuaJun Jin; QiJun Qian
Journal:  J Cancer       Date:  2015-07-16       Impact factor: 4.207

8.  Argonaute 2 and nasopharyngeal carcinoma: a genetic association study and functional analysis.

Authors:  Peiyao Li; Jinfeng Meng; Yun Zhai; Hongxing Zhang; Lixia Yu; Zhifu Wang; Xiaoai Zhang; Pengbo Cao; Xi Chen; Yuqing Han; Yang Zhang; Huipeng Chen; Yan Ling; Yuxia Li; Ying Cui; Jin-Xin Bei; Yi-Xin Zeng; Fuchu He; Gangqiao Zhou
Journal:  BMC Cancer       Date:  2015-11-06       Impact factor: 4.430

9.  Control of the localization and function of a miRNA silencing component TNRC6A by Argonaute protein.

Authors:  Kenji Nishi; Tomoko Takahashi; Masataka Suzawa; Takuya Miyakawa; Tatsuya Nagasawa; Yvelt Ming; Masaru Tanokura; Kumiko Ui-Tei
Journal:  Nucleic Acids Res       Date:  2015-10-07       Impact factor: 16.971

10.  AGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cells.

Authors:  Yanhui Zhang; Baoxin Wang; Xinwei Chen; Weidong Li; Pin Dong
Journal:  Oncotarget       Date:  2017-05-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.